Terry L. Murdock, Chief Operating Officer at G1 Therapeutics, Inc. (GTHX), sold 1,361 shares at $2.45 ($3K) on 2023-07-05, disclosed to the SEC on 2023-07-07.
Scheduled sale ($3k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GTHX | SELL | 2024-01-08 | $12K | — | Filing → |
| GTHX | SELL | 2023-01-05 | $13K | — | Filing → |
| GTHX | SELL | 2022-07-06 | $3K | — | Filing → |